Trial Profile
A PK-loading study of q3w Herceptin (trastuzumab) monotherapy in women with HER2 positive metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2010
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Roche
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 30 Mar 2007 New trial record.